Medline Inc. Q1 2026 Results: $2.45 B Revenue, Oncology Pipeline Advances and Strong Cash Position
Medline Inc. Q1 2026: $2.45B revenue, $325M operating income, and strong oncology/immunology pipeline with Phase 3 and regulatory milestones, driving future growth.
4 minutes to read